Children's Hospital of New Orleans is a non-profit, pediatric acute care children's teaching hospital located in New Orleans, Louisiana. The hospital has 229 pediatric beds and is affiliated the Louisiana State University Health Sciences Center.

There are 229 beds in Children's Hospital New Orleans.

During the past decade, Children's Hospital New Orleans conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 63 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 22 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Hospital New Orleans" #1 sponsor was "Children's Oncology Group" with 105 trials, followed by "National Cancer Institute (NCI)" with 46 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials sponsored, "Chimerix" with 4 trials sponsored and "Roswell Park Cancer Institute" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Hospital New Orleans" #1 collaborator was "National Cancer Institute (NCI)" with 110 trials as a collaborator, "Children's Oncology Group" with 6 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "National Center for Advancing Translational Sciences (NCATS)" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Children's Hospital New Orleans" are "Recurrent Neuroblastoma" (21 trials), "Leukemia" (18 trials), "Refractory Neuroblastoma" (15 trials), "Refractory Non-Hodgkin Lymphoma" (14 trials) and "Recurrent Hepatoblastoma" (13 trials). Many other conditions were trialed in "Children's Hospital New Orleans" in a lesser frequency.

Most popular intervention types in "Children's Hospital New Orleans" are "Drug" (154 trials), "Other" (89 trials), "Procedure" (63 trials), "Biological" (62 trials) and "Radiation" (47 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (49 trials), "Cyclophosphamide" (33 trials), "Vincristine Sulfate" (30 trials), "Doxorubicin Hydrochloride" (25 trials) and "Etoposide" (25 trials). Other intervention names were less common.

The vast majority of trials in "Children's Hospital New Orleans" are 202 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Children's Hospital New Orleans". undefined are not yet recruiting, 41 are recruiting, 51 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 95 completed trials in Children's Hospital New Orleans, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Hospital New Orleans, 6 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".